[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551211":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":41,"responsibleParty":60,"collaborators":26,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":26,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":26,"enrollmentInfo":72,"targetDuration":26,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":82,"overallStatus":44,"whyStopped":26,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"University of Massachusetts, Worcester","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Early Postpartum GDM Screening","EXPERIMENTAL","Subjects who are randomly assigned to this condition will be screened for GDM with the recommended 2-hour glucose tolerance test during their postpartum hospitalization.",[13],"Diagnostic Test: Glucose tolerance test (2 hour)",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard of Care Postpartum Screening","ACTIVE_COMPARATOR","Subjects randomized to the comparison condition will receive the usual standard of care. The standard of care will consist of screening with a 2 hour glucose tolerance test at 6-12 weeks postpartum.",[19],"Other: Active Comparator",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIAGNOSTIC_TEST","Glucose tolerance test (2 hour)","Early testing with the 2 hour glucose tolerance test will occur during their inpatient postpartum hospitalization.",[9],null,{"type":6,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Active Comparator","Subjects randomized to the comparison condition will receive the usual standard of care. The standard of care will consist of administration of educational materials adapted from the American Diabetes Association that discusses healthy lifestyle behaviors and the increased risks of developing T2DM after a pregnancy complicated by GDM.",[15],[32],{"name":33,"affiliation":34,"role":35},"Gianna Wilkie, MD","UMASS Memorial Healthcare","PRINCIPAL_INVESTIGATOR",[37],{"name":33,"role":38,"phone":39,"phoneExt":26,"email":40},"CONTACT","508-3444982","Gianna.Wilkie@umassmemorial.org",[42],{"facility":43,"status":44,"city":45,"state":46,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"University of Massachusetts Memorial Medical Center","RECRUITING","Worcester","Massachusetts","01605","United States","US",{"type":51,"coordinates":52},"Point",[53,54],-71.80229,42.26259,{"lat":54,"lon":53},[57],{"name":58,"role":38,"phone":59,"phoneExt":26,"email":40},"Gianna L Wilkie, MD","508-334-4067",{"type":35,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Gianna Wilkie","Assistant Professor","100551211","preventing-t2dm-after-gdm-with-immediate-postpartum-screening-100551211",false,"NCT06457139","Preventing T2DM After GDM With Immediate Postpartum Screening","Preventing Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus With Immediate Postpartum Screening","Inclusion Criteria:\n\n* pregnancy complicated by GDM as diagnosed with traditional two step testing in the third trimester according to Carpenter-Coustan Criteria\n* receiving prenatal care at UMASS Memorial and plans to deliver at UMASS Memorial\n* able and willing to provide informed consent\n* ability to complete immediate in hospital postpartum glucose testing\n* have evidence of impaired glucose metabolism defined as fasting glucose value of ≥126 mg\u002FdL or 2-hour glucose value of ≥200 mg\u002FdL\n\nExclusion Criteria:\n\n* known diagnosis of pre-existing pre-gestational diabetes in pregnancy\n* inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test) in pregnancy or immediately postpartum\n* systemic steroid use","FEMALE","18 Years",{"count":73,"type":74},116,"ESTIMATED","INTERVENTIONAL",[77],"NA","The overall goal of this proposal is to create and test an implementation protocol for in-hospital immediate postpartum diabetes screening for postpartum patients with pregnancies affected by GDM.",[80,81],"Gestational Diabetes","Type 2 Diabetes",[83],"diabetes","2026-06-19",{"date":86,"type":87},"2026-06-24","ACTUAL",{"date":89,"type":87},"2025-06-01",{"date":91,"type":74},"2027-12-01",{"name":5,"class":6},1]